Skip to main content

IRadimed Corporation (IRMD)

NASDAQ: IRMD · Delayed Price · USD
33.69 -0.07 (-0.21%)
Sep 23, 2021 4:00 PM EDT - Market closed
Market Cap415.86M
Revenue (ttm)35.28M
Net Income (ttm)4.57M
Shares Out12.31M
EPS (ttm)0.36
PE Ratio92.81
Forward PE41.67
Dividendn/a
Ex-Dividend Daten/a
Volume82,000
Open33.76
Previous Close33.76
Day's Range32.91 - 34.15
52-Week Range20.52 - 40.51
Beta1.05
AnalystsBuy
Price Target38.00 (+12.8%)
Est. Earnings DateOct 29, 2021

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensor...

IndustryHealth Care Equipment & Supplies
IPO DateJul 16, 2014
CEORoger Susi
Employees110
Stock ExchangeNASDAQ
Ticker SymbolIRMD
Full Company Profile

Financial Performance

In 2020, IRadimed's revenue was $31.72 million, a decrease of -17.65% compared to the previous year's $38.52 million. Earnings were $1.37 million, a decrease of -85.79%.

Financial Statements

Analyst Forecast

According to one analyst, the rating for IRadimed stock is "Buy" and the 12-month stock price forecast is 38.00.

Price Target
$38.00
(12.79% upside)
Analyst Consensus: Buy

News

IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...

1 month ago - GlobeNewsWire

IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

iRadimed (IRMD) Stock Jumps 11.3%: Will It Continue to Soar?

iRadimed (IRMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t...

2 months ago - Zacks Investment Research

IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th

WINTER SPRINGS, Fla., July 07, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market open...

2 months ago - GlobeNewsWire

Here's What Could Help iRadimed (IRMD) Maintain Its Recent Price Strength

iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho...

3 months ago - Zacks Investment Research

IRadimed (IRMD) Q1 Earnings and Revenues Top Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 44.44% and 10.34%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

IRADIMED CORPORATION Announces First Quarter 2021 Financial Results

WINTER SPRINGS, Fla., April 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices...

4 months ago - GlobeNewsWire

Earnings Outlook for iRadimed

iRadimed (NASDAQ:IRMD) announces its next round of earnings this Friday, April 30. Here is Benzinga's look at iRadimed's Q1 earnings report.

4 months ago - Benzinga

IRADIMED CORPORATION to Hold 2021 First Quarter Financial Results Conference Call on April 30th

WINTER SPRINGS, Fla., April 09, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market open...

5 months ago - GlobeNewsWire

IRADIMED CORPORATION to Hold 2020 Fourth Quarter Financial Results Conference Call on February 4th

WINTER SPRINGS, Fla., Jan. 27, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market open...

7 months ago - GlobeNewsWire

A Trio of Stocks Growing Revenue Per Share Fast

The S&P 500 Index stocks saw their aggregate trailing 12-month real revenue per share rise at a compound average growth rate (CAGR) of 1.97% per annum over the past five years, which occurred alongside ...

Other symbols:EXPIFLNT
9 months ago - GuruFocus

IRadimed Corporation (IRMD) CEO Roger Susi on Q3 2020 Results - Earnings Call Transcript

IRadimed Corporation (IRMD) CEO Roger Susi on Q3 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

IRadimed Corporation's (IRMD) CEO Roger Susi On Q3 2020 Results - Quick Version Earnings Call Transcript

IRadimed Corporation's (IRMD) CEO Roger Susi On Q3 2020 Results - Quick Version Earnings Call Transcript

10 months ago - Seeking Alpha

IRadimed (IRMD) Q3 Earnings and Revenues Top Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 120.00% and 3.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

IRADIMED CORPORATION Announces Third Quarter 2020 Financial Results

WINTER SPRINGS, Fla., Oct. 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices ...

10 months ago - GlobeNewsWire

Analysts Estimate iRadimed (IRMD) to Report a Decline in Earnings: What to Look Out for

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

11 months ago - Zacks Investment Research

IRADIMED CORPORATION to Hold 2020 Third Quarter Financial Results Conference Call on October 30th

WINTER SPRINGS, Fla., Oct. 08, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market opens...

11 months ago - GlobeNewsWire

IRadimed Corp (IRMD) CEO Roger Susi on Q2 2020 Results - Earnings Call Transcript

IRadimed Corp (IRMD) CEO Roger Susi on Q2 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

IRadimed (IRMD) Beats Q2 Earnings and Revenue Estimates

iRadimed (IRMD) delivered earnings and revenue surprises of 225.00% and 22.96%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results

WINTER SPRINGS, Fla., July 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical device...

1 year ago - GlobeNewsWire

Earnings Preview: iRadimed (IRMD) Q2 Earnings Expected to Decline

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th

WINTER SPRINGS, Fla., July 16, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market op...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Names Roger Susi as President and Chief Executive Officer

WINTER SPRINGS, Fla., May 29, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company’s P...

1 year ago - GlobeNewsWire

IRADIMED CORPORATION Announces Issuance of U.S. Patent

Latest patent expands previous claims around IRADIMED’s wireless communication as used to remotely control an IV pump Latest patent expands previous claims around IRADIMED’s wireless communication as us...

1 year ago - GlobeNewsWire

IRadimed's (IRMD) CEO Leslie McDonnell on Q1 2020 Results - Earnings Call Transcript

IRadimed's (IRMD) CEO Leslie McDonnell on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha